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tumors, keratin, EMA, vimentin and CEA and, sometimes,
hCG. Additional immunohistochemistry was adopted when
required to improve the pathological diagnosis. Candidate
patients to cystectomy, for reason other than large bladder tumor
with radiologic imaging suggestive of bladder wall infiltration,
i.e. Tis, multiple and/or recurrent non muscle invasive and
patients submitted to TURBT at other centers, were excluded.
Inferential statistical analysis was performed. Results: Out of
340 patients, 35 (10.3%) showed rare histotypes of bladder
cancer, i.e. in 30 cases (32%) out of 94 radical cystectomies and
in 5 (2%) out of 246 TURBTs. The rare histotypes were
distributed as follows: squamous carcinoma 11 (31%),
sarcomatoid 8 (23%), undifferentiated 6 (17%), neuroendocrine
3 (9%), micropapillary 2 (6%), adenocarcinoma 1 (3%), mixed
4 (11%). TCCB with histological rare variants showed at
cystectomy considerable size (average diameter=7.7×6.7 cm;
range=4.5×5-11×9 cm), while 13 (43%) were pT4 category. In
13 patients (37%), the uncommon histotype was detected at the
pre-operative TURBT, while, in 22 (63%), it was recognized
only in the cystectomy specimen. Regarding the correlation
between TURBT and re-TUR, rare histotypes were not
identified at the first TURBT in 9 patients (26%) but found at
re-TURBT in 4 patients (44%) and at cystectomy in 5 patients
(56%) (Figure 1). Conversely, an atypical component diagnosed
at first TURBT was not confirmed by a subsequent re-TUR in
only 1 patient (3%). Discussion: Although the important
prognostic role of rare histologic variants of bladder cancer is
well-recognized, TURBT is not standardized in relation to
tumor size. Unrecognized rare histotypes might have important
therapeutic implications since they are probably less responsive
to neoadjuvant chemotherapy or bladder-sparing approaches,
thus benefiting early cystectomy. The inaccuracy of TUR in
everyday clinical practice in detecting uncommon variants could
be explained by the inadequacy of sampling of large tumors.
The “pre-cystectomy” TUR is often considered a limited biopsy
to confirm the tumor and to demonstrate the infiltration of the
muscular layer. As a matter of fact, pathologists often do not
analyze a sufficient amount of tissue to identify different
histological components. Standardization of the TURBT
strategy, including sampling of different areas of bulky tumors,
could be of clinical value.
Figure 1. Flow chart showing the correlation between TURBT, re-
TUR and cystectomy.
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Introduction: Detailed reporting of resection strategies (RS)
and resection techniques (RT) for tumor excision during partial
nephrectomy (PN) is lacking in the current literature. The aim
of the study was to evaluate (i) possible correlations between
patients’ and/or tumors’ characteristics and RT performed and
(ii) whether the type of RT does influence perioperative
outcomes after PN, harnessing the newly proposed Surface-
Intermediate-Base (SIB) margin score as a standardized
reporting system. Materials and Methods: After Institutional
Review Board’s approval, data were prospectively collected
from a cohort of 507 patients undergoing NSS at 16 high-
volume Centers across the U.S. and Europe over a 6-month
enrollment period. RT was classified according to the SIB
score. RS was classified as “enucleative”, “enucleoresective”
or “resective” according to the most prevalent RT performed
in each centre’s cohort. Descriptive and comparative analyses
were performed in the six enucleoresective RS centres (ERC).
Results: Overall, 507 patients were finally enrolled in the study.
The RT was classified as pure or hybrid enucleation (E, SIB 0-
2), pure or hybrid enucleoresection (ER, SIB 3-4) and resection
(R, SIB 5) in 266 (52.5%), 150 (29.6%) and 91(17.9%)
patients, respectively, in the overall cohort, while in 53
(33.1%), 83 (51.9%) and 24 (15.0%) patients in the ERC.
Demographic data, comorbidity scores, surgical indication and
approach and PADUA score did not significantly differ
between the E, ER and R groups in the ERC. Tumors >4.0 cm
were 21 (40.4%), 41 (49.4%) and 4 (16.7%) in the E, ER and
R groups (p=0.02), respectively. A clampless strategy was used
in 19.2%, 13.2% and 8.3% of patients (p>0.05). Median warm
ischemia time (WIT) was 19 (15-24), 17 (14-23) and 17 (15-
21) minutes in the E, ER and R groups (p>0.05). Surgical post-
operative complications were recorded in 7.5%, 13.2% and
4.2% of patients (p=0.05). Positive surgical margin rate was
7.0%, 13.4% and 0% of patients, respectively (p>0.05).
Trifecta outcome was achieved in 67.2%, 71.6% and 73.7% of
patients for the E, ER and R groups (p>0.05). Discussion and
Conclusions: This is the first study evaluating pre-operative
predictive factors of RTs performed during PN and whether the
type of RT significantly impacts on NSS outcomes using a
standardized instrument of reporting. Overall, in ERC, ER
represents less than 52%. ER and E are performed in a
significantly higher proportion of tumors >4 cm compared to
R. Relating to surgical outcomes, ER was associated with a
significantly higher rate of post-operative surgical complication
compared to E and R. However, Trifecta achievement was
comparable among the three techniques.
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Introduction/Aim: Resection methodology is rarely reported in
current nephron-sparing surgery (NSS) literature. Yet, a
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